Bank of America’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.63M | Buy |
|
|||||
|
2025
Q1 | $2.18M | Buy |
|
|||||
|
2024
Q4 | $772K | Buy |
|
|||||
|
2024
Q3 | $844K | Buy |
|
|||||
|
2024
Q2 | $1.11M | Buy |
|
|||||
|
2024
Q1 | $796K | Sell |
|
|||||
|
2023
Q4 | $1.07M | Buy |
|
|||||
|
2023
Q3 | $607K | Buy |
|
|||||
|
2023
Q2 | $327K | Sell |
|
|||||
|
2023
Q1 | $1.21M | Buy |
|
|||||
|
2022
Q4 | $1.07M | Buy |
|
|||||
|
2022
Q3 | $999K | Sell |
|
|||||
|
2022
Q2 | $1.01M | Sell |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $392K | Buy |
|
|||||
|
2021
Q3 | $614K | Sell |
|
|||||
|
2021
Q2 | $1.37M | Buy |
|
|||||
|
2021
Q1 | $650K | Sell |
|
|||||
|
2020
Q4 | $616K | Buy |
|
|||||
|
2020
Q3 | $250K | Sell |
|
|||||
|
2020
Q2 | $357K | Buy |
|
|||||
|
2020
Q1 | $228K | Buy |
|
|||||
|
2019
Q4 | $297K | Sell |
|
|||||
|
2019
Q3 | $223K | Buy |
|
|||||
|
2019
Q2 | $241K | Sell |
|
|||||
|
2019
Q1 | $717K | Buy |
|
|||||
|
2018
Q4 | $81K | Buy |
|
|||||
|
2018
Q3 | $50K | Hold |
|
|||||
|
2018
Q2 | $53K | Buy |
|